SAMLYN CAPITAL, LLC

Q4 2022 13F-HR Holdings

Location
New York, NY
Holdings as of
12/31/2022
Date filed
2/14/2023
Form type
13F-HR
Num holdings
91
Total value ($000)
$5,108,272
Net value change ($000)
-271,605 (-5.0%)
New positions
28
Sold out positions
26
Turnover %
44.4%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 11/14/2022 Next filing: 5/15/2023 SEC filing

Snapshot: Change Analysis

Compared to Q3 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
META 149,304 1668.4%
APO 112,661 NEW
WDAY 110,126 NEW
TJX 94,983 521.8%
LULU 94,133 NEW
AXP 84,837 128.2%
CROX 78,976 109.7%
NTRA 76,577 76.7%
ICE 68,768 NEW
IBKR 66,675 NEW
Top Reduces (Value $000, Stocks/ETFs)
DIS -279,569 -100.0%
PYPL -174,961 -100.0%
THC -124,238 -85.7%
TPR -99,369 -100.0%
ORLY -83,367 -100.0%
PANW -78,268 -45.1%
EQH -76,725 -66.3%
MSFT -71,326 -100.0%
CI -61,197 -60.7%
Horizon Therapeutics Public Ltd Co -60,286 -62.4%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 7,461 (0.1% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type